Free Trial

Insider Selling: UiPath, Inc. (NYSE:PATH) CEO Sells 45,000 Shares of Stock

UiPath logo with Computer and Technology background

UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Monday, July 21st. The shares were sold at an average price of $12.72, for a total transaction of $572,400.00. Following the completion of the sale, the chief executive officer owned 4,923,376 shares of the company's stock, valued at approximately $62,625,342.72. This represents a 0.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Daniel Dines also recently made the following trade(s):

  • On Friday, July 18th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.38, for a total transaction of $557,100.00.
  • On Wednesday, July 16th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00.
  • On Wednesday, July 16th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00.
  • On Monday, July 14th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.44, for a total transaction of $559,800.00.
  • On Friday, July 11th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.71, for a total transaction of $571,950.00.
  • On Wednesday, July 9th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $13.17, for a total transaction of $592,650.00.
  • On Monday, July 7th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $13.11, for a total transaction of $589,950.00.
  • On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.54, for a total transaction of $564,300.00.
  • On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.78, for a total transaction of $575,100.00.
  • On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.78, for a total transaction of $575,100.00.

UiPath Stock Up 0.0%

UiPath stock traded up $0.01 during mid-day trading on Wednesday, hitting $12.60. 5,043,407 shares of the stock were exchanged, compared to its average volume of 10,465,986. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93. The firm's fifty day simple moving average is $12.75 and its two-hundred day simple moving average is $12.45. The stock has a market capitalization of $6.74 billion, a price-to-earnings ratio of -104.95, a PEG ratio of 16.31 and a beta of 1.04.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same quarter last year, the business earned $0.13 EPS. The company's revenue was up 6.4% compared to the same quarter last year. As a group, analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Institutional Trading of UiPath

Several hedge funds have recently modified their holdings of PATH. KLP Kapitalforvaltning AS increased its stake in UiPath by 10.9% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 88,600 shares of the company's stock valued at $1,134,000 after purchasing an additional 8,700 shares in the last quarter. 111 Capital bought a new stake in shares of UiPath in the 2nd quarter worth $167,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of UiPath by 7.4% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 80,324 shares of the company's stock worth $1,028,000 after acquiring an additional 5,513 shares in the last quarter. Patriot Financial Group Insurance Agency LLC bought a new stake in shares of UiPath in the 2nd quarter worth $275,000. Finally, Robeco Institutional Asset Management B.V. bought a new stake in shares of UiPath in the 2nd quarter worth $208,000. Institutional investors own 62.50% of the company's stock.

Wall Street Analysts Forecast Growth

PATH has been the topic of several recent analyst reports. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Friday, May 30th. BMO Capital Markets raised their target price on shares of UiPath from $11.50 to $15.50 and gave the company a "market perform" rating in a report on Friday, May 30th. Mizuho decreased their target price on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Canaccord Genuity Group set a $16.00 price target on shares of UiPath and gave the company a "buy" rating in a research note on Monday, June 2nd. Finally, Royal Bank Of Canada raised their price target on shares of UiPath from $13.00 to $15.00 and gave the company a "sector perform" rating in a research note on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, UiPath presently has an average rating of "Hold" and a consensus target price of $13.83.

Get Our Latest Stock Analysis on UiPath

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines